CD44+ CD90+ CSCs from small cell lung cancer (SCLC) show upregulation of Lag-3 and TIM-3 along with overexpression of the common checkpoints PD-(L)1 and CTLA-4. This evidence concerns the gene HAVCR2 and small cell lung carcinoma.